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A 12-year-old girl was admitted to hospital with a week’s history of 
severe abdominal pain, distension and generalised weakness, and 
was managed for incomplete intestinal obstruction. Plain abdominal 
films were compatible with ileus, and ultrasound showed no ascites, 
no lymphadenopathy, and normal abdominal and pelvic organs. We 
saw her following the onset of new generalised tonic-clonic seizures. 
She was slightly obtunded with raised blood pressure (166/115 
mmHg) and sinus tachycardia (130 bpm), apyrexial, and had mild 
psychomotor retardation and blindness with no light perception in 
either eye. Fundoscopy was normal. There was no meningism or 
sensorimotor deficit. Apart from a marginally low serum sodium 
level (131 mmol/l), the results of all biochemical and haematological 
investigations were normal. Inflammatory markers (c-reactive 
protein, erythrocyte sedimentation rate and procalcitonin) and 
cerebrospinal fluid assessment were normal.
A computed tomography (cT) scan of her brain showed bilateral 
hypodense parieto-occipital white matter changes consistent with 
oedema (Fig. 1). MRI scanning revealed prominent cortical and 
subcortical hyperintensities in the occipital and high parietal regions 
consistent with the radiological phenomenon of posterior reversible 
encephalopathy syndrome (PRES) (Fig. 2).
The patient’s vision returned following normalisation of her blood 
pressure with β-blockers. A suspicion of acute intermittent porphyria 
(AIP) was confirmed when a markedly elevated porphyrin level was 
detected in her blood and urine (urinary aminolaevulanic acid 1 521 
μmol/10 mmol creatinine, normal <45; urinary porphobilinogen 
1 426 μmol/10 mmol creatinine, normal <16, with a positive 
plasma peak at 619 nm). Her abdominal pain and hyponatraemia 
resolved following commencement of a high-carbohydrate diet and 
administration of intravenous haem arginate. She was discharged 12 
days after admission, completely well.
Discussion
First described by Hirchey et al. in 1996,1 PRES is a term for a 
radiologico-clinical entity of vasogenic cerebral oedema mainly 
in the parietal and occipital white matter regions, and presenting 
with neurological symptoms including headache, altered mental 
state, visual disturbances, seizures etc. PRES is seen in a variety of 
clinical scenarios including pre-eclampsia/eclampsia and accelerated 
hypertension, and less commonly in sepsis and with the use of 
immunosuppressive agents, e.g. tacrolimus.2 In 70 - 80% of cases, 
moderate to severe hypertension is observed; indeed, ‘hypertensive 
encephalopathy’ is understood to be the clinical correlate of PRES.2 
Hypomagnesaemia has also been associated with PRES.3
The white matter lesions best seen on MRI represent vasogenic 
oedema that is reversible with removal of the underlying cause. Its 
predilection for the posterior cerebral region is thought to be due 
to a deficiency in autoregulation owing to a paucity of sympathetic 
innervation to the posterior vasculature.4 It is commonly accepted that 
a severely elevated BP exceeds the upper limits of cerebro-vascular 
autoregulation, causing capillary endothelial injury and subsequent 
leakage leading to the vasogenic oedema observed.3 An immune-
mediated cascade involving T-lymphocytes, various cytokines and 
endothelial adhesion molecules causing endothelial dysfunction and 
triggering cerebral vasoconstriction and hypoperfusion, may explain 
the absence of a raised BP in some cases of PRES.3
We found 5 other cases of PRES occurring in AIP.4-6 Presumably, 
PRES observed in AIP is secondary to the accelerated hypertension 
that may be observed as part of the autonomic hyperactivity of AIP. 
Our evidence for this is in the temporal relationship between the 
elevated BP and onset of PRES symptomatology (blindness, seizures, 
psychomotor retardation) and their resolution following treatment 
of the hypertension. Although AIP does present with neurological 
symptoms (altered mental status, motor weakness, abdominal pain, 
autonomic hyperactivity, etc.), its pathogenetic mechanism and 
range of symptoms (especially its involvement of the peripheral Corresponding author: E Gardiner (gardiner.emmacora@gmail.com)
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Fig. 1. CT scan depicting hypodense white matter changes in the occipital 
lobe, consistent with vasogenic oedema.
Fig. 2. T2-weighted fluid-attenuated inversion recovery (FLAIR) images 
showing bilateral hyperintense lesions in the occipital lobe white matter. 
These changes are indicative of vasogenic oedema. The MRI scan was done 
within 5 hours of the brain CT.
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nervous system) are quite distinct from what is observed in PRES. 
Furthermore, the resolution of the symptoms we attributed to 
PRES in the face of persisting hyperporphyrinaemia (abdominal 
pain persisting and urinary porphyrins still elevated after seizures 
and blindness resolved) makes it unlikely that they were due to the 
porphyrin neurotoxicity of AIP.
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